Tianjin Smith Kline &French Laboratorles Ltd is a consumer health product company jointly invested and established by GlaxoSmithKline (GSK), one of the global pharmaceutical companies, and large domestic pharmaceutical companies Tianjin Zhongxin Pharmaceutical Co., Ltd. and Tianjin Taiping (Group) Co., Ltd.

As one of the foreign joint venture pharmaceutical factories established in China as early as 1987, Sino-U.S. SmithKline took root in China. For more than 20 years, Sino-U.S. SmithKline has always adhered to the concept of great love and dedication, using products and love to repay society, patients, and consumers. In 2008, in addition to the well-known four OTC brands New Contac, Fenbid, Baiduobang, and Shike Enterococcal Cleansing, the Sino American Shike family also successfully launched the globally recommended anti tooth sensitive toothpaste Comforter; New members have been added to the two major brand families, New Contaiq and Fenbid. In 2008, New Contaiq's red heavy-duty clothing was successfully launched; In 2009, the new headache kit of Fenbid Phenolic Coffee Tablets was successfully launched. In 2010, another refreshing oral care new brand, "Poly Jing", was successfully launched by SinoSmithKline, providing a care plan for denture wearers in China! In the same year, Kontec nasal patches were launched, creating an innovative healthy choice for Chinese consumers to relieve nasal symptoms!

In addition, Sino-U.S. SmithKline has been tirelessly studying the needs of Chinese consumers and leveraging global power to continuously launch products to protect the healthy lives of Chinese consumers.